
GHRP-2 5mg ×10 + Ipamorelin 5mg ×10 (Bundle)
CAS: GHRP-2: 158861-67-7 | Ipamorelin: 170851-70-4
The GHRP-2 & Ipamorelin 5mg ×10 Bundle by BioPeptides is a high-purity research-grade peptide combination designed for advanced laboratory studies in growth hormone signaling, ghrelin receptor activation, and endocrine pathway analysis. This bundle includes GHRP-2 (CAS 158861-67-7) and Ipamorelin (CAS 170851-70-4), each supplied in ten individual 5mg vials for experimental flexibility and long-term research workflows. Purified to ≥99% HPLC, the peptides provide consistent molecular performance for controlled biochemical and in-vitro research. Laboratories across Europe rely on BioPeptides to buy peptides online with confidence through EU-friendly logistics and verified analytical documentation.
$1240.00
Research Use Only
GHRP-2 & Ipamorelin Research Overview
The GHRP-2 & Ipamorelin bundle combines two growth hormone secretagogue peptides commonly studied in endocrine signaling research.
GHRP-2 activates ghrelin receptors and is widely investigated for its role in growth hormone release signaling pathways.
Ipamorelin is studied for its selective ghrelin receptor interaction and focused endocrine signaling profile.
Together, these peptides allow researchers to explore receptor sensitivity, signal intensity, and downstream cellular responses in controlled laboratory models.

Scientific Background of GHRP-2 & Ipamorelin
Growth hormone secretagogues interact with ghrelin receptors to influence endocrine signaling pathways related to hormone release.
GHRP-2 is frequently used in research models to investigate strong receptor activation and robust GH signaling dynamics.
Ipamorelin is studied for its selective receptor interaction profile, allowing researchers to analyze signaling specificity and receptor selectivity.
In laboratory environments, combining these peptides enables comparative analysis of signal strength, receptor efficiency, and endocrine feedback mechanisms.

Mechanistic Research Perspective
- Ghrelin receptor activation and secretagogue signaling pathway analysis
- Growth hormone release pathway modeling
- Receptor interaction and ligand binding studies
- Signal intensity versus selectivity comparison
- Endocrine feedback loop and pathway coordination research
Primary Research Applications
Growth Hormone Release Studies: The bundle is used in laboratory research to analyze GH secretion dynamics, signaling thresholds, and endocrine pathway responses.
Ghrelin Receptor Signaling Research: Researchers study receptor activation patterns and ligand interaction behavior using both secretagogues.
Endocrine System Modeling: The peptide combination allows scientists to investigate hormone regulation mechanisms and endocrine feedback processes.
Cellular & Molecular Biology Studies: Laboratories apply this bundle in cell-based assays exploring intracellular signaling cascades and gene expression responses.
In-Vitro and Preclinical Research Models: The bundle is commonly incorporated into controlled non-clinical models studying endocrine signaling and receptor-mediated pathways.
Molecular Characteristics
- Peptide Type: Growth hormone secretagogue peptides
- GHRP-2 CAS Identifier: 158861-67-7
- Ipamorelin CAS Identifier: 170851-70-4
- GHRP-2 Molecular Weight: ~817.9 g/mol
- Ipamorelin Molecular Weight: ~711.9 g/mol
- Form: Lyophilized peptide powders supplied in separate vials
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C for long-term stability
- Protect vials from moisture and light exposure
- Avoid repeated freeze–thaw cycles after reconstitution
- Reconstitute using sterile laboratory-grade solvent
- Handle peptides using aseptic laboratory techniques
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solutions
- Buffered aqueous laboratory solutions
- Standard biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
GHRP-2 5mg ×10 + Ipamorelin 5mg ×10 Bundle
brand
BioPeptides
cas
158861-67-7 | 170851-70-4
purity
≥99% (HPLC verified)
unit Size
5mg ×10 vials each peptide
form
Lyophilized powder (separate vials)
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Synthetic peptide hormones
stability
High when stored appropriately
Analytical Validation and Quality Assurance
- High-performance liquid chromatography (HPLC) purity verification
- Mass spectrometry molecular weight confirmation
- Structural integrity and peptide sequence validation
- Batch-to-batch consistency testing
- Peptide stability and analytical verification
Frequently Asked Questions
This bundle is used in laboratory research to study growth hormone release mechanisms, ghrelin receptor signaling, endocrine pathway interactions, and comparative secretagogue behavior in controlled, non-clinical research environments.
GHRP-2 is studied for its strong receptor activation and robust GH signaling, while Ipamorelin is researched for its selective receptor interaction, allowing comparison of signaling intensity versus pathway specificity.
Multiple vials improve stability, reduce degradation risk, and allow flexible experimental scheduling across long-term research programs without repeated freeze-thaw exposure.
Yes. The bundle is widely used in controlled in-vitro and preclinical research models focused on receptor binding, intracellular signaling, and endocrine regulation.
Yes. Researchers frequently use this combination to compare signaling efficiency, receptor sensitivity, and downstream pathway activation between different GH secretagogues.
Store lyophilized vials at -20°C, reconstitute only with sterile laboratory solvent, and avoid repeated freeze-thaw cycles to maintain molecular stability.
Yes. BioPeptides ships this research bundle to multiple European countries using secure, EU-compliant logistics and professional packaging.
BioPeptides is trusted for high-purity synthesis, verified CAS documentation, consistent batch quality, and strict adherence to European research standards.
